DOX(DOX)
DOX
Q4 2026 EPS Estimate
$1.98
Nov 10, 2026 · Reports after close
Revenue Estimate
$1.19B
FY2026E EPS$7.42
FY2027E EPS$8.07
Analyst Sentiment
Wall St. Consensus
Buy10 analysts·Moderate coverage
68
Score
7 Buy (70%)3 Hold (30%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
770%
Hold
330%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$71.00
+17.9%
Consensus
$71.00
+17.9%
Bull
$71.00
+17.9%
12-Month Target Range10 analysts
$71.00$71.00$71.00
Current $60.21Consensus
Current Price
$60.21
Upside to Consensus
$10.79
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+3.64%
EPS+8.79%
FY2028
Rev+4.36%
EPS+13.16%
FY2029
Rev+3.99%
EPS+10.51%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $4.70B | $4.87B | $5.08B | $5.28B | $5.49B |
| Low | $4.69B | $4.86B | $5.05B | $5.25B | $5.46B |
| High | $4.72B | $4.89B | $5.11B | $5.30B | $5.52B |
| EBITDA Avg | $922M | $955M | $997M | $1.04B | $1.08B |
| Low | $920M | $953M | $990M | $1.03B | $1.07B |
| High | $925M | $959M | $1.00B | $1.04B | $1.08B |
| EBIT Avg | $716M | $742M | $774M | $805M | $837M |
| Low | $714M | $740M | $769M | $799M | $831M |
| High | $718M | $745M | $779M | $808M | $840M |
| Net Income Avg | $829M | $902M | $1.02B | $1.13B | $1.24B |
| Low | $826M | $883M | $1.01B | $1.12B | $1.23B |
| High | $832M | $922M | $1.03B | $1.13B | $1.25B |
| EPS Avg | $7.42 | $8.07 | $9.13 | $10.09 | $11.14 |
| Low | $7.40 | $7.90 | $9.05 | $10.00 | $11.04 |
| High | $7.45 | $8.25 | $9.18 | $10.14 | $11.20 |
| Analysts (Rev / EPS) | 5 / 4 | 5 / 4 | 2 / 1 | 1 / 1 | 1 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 |
|---|---|---|---|---|---|
| Revenue Avg | $1.19B | $1.20B | $1.21B | $1.21B | $1.24B |
| Low | $1.19B | $1.20B | $1.21B | $1.21B | $1.24B |
| High | $1.20B | $1.20B | $1.22B | $1.22B | $1.24B |
| EBITDA Avg | $234M | $236M | $238M | $238M | $243M |
| Low | $234M | $236M | $238M | $237M | $242M |
| High | $236M | $236M | $239M | $238M | $243M |
| EBIT Avg | $182M | $183M | $185M | $184M | $188M |
| Low | $182M | $183M | $185M | $184M | $188M |
| High | $183M | $183M | $186M | $185M | $189M |
| Net Income Avg | $209M | $205M | $210M | $211M | $220M |
| Low | $207M | $203M | $210M | $211M | $220M |
| High | $212M | $208M | $211M | $212M | $221M |
| EPS Avg | $1.98 | $1.94 | $1.99 | $2.00 | $2.08 |
| Low | $1.96 | $1.92 | $1.98 | $2.00 | $2.08 |
| High | $2.01 | $1.97 | $1.99 | $2.01 | $2.09 |
| Analysts (Rev / EPS) | 4 / 4 | 3 / 4 | 1 / 1 | 1 / 1 | 1 / 1 |